STOCK TITAN

Factorial signs MOU with Philenergy to scale Solstice™ manufacturing (CGCT)

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
425

Rhea-AI Filing Summary

Cartesian Growth Corporation III files an 8-K reporting that Factorial Inc. entered a non-binding MOU with Philenergy Co., Ltd. to explore a strategic manufacturing collaboration to scale Factorial’s Solstice™ all-solid-state battery platform.

The MOU is non-binding and the proposed collaboration is subject to the negotiation and execution of definitive agreements and the satisfaction of customary conditions. The filing also reiterates that Factorial and Cartesian III are pursuing a proposed business combination and intend to file a Form S-4 in connection with that transaction.

Positive

  • None.

Negative

  • None.

Insights

Non-binding MOU signals early-stage manufacturing talks, not a committed transaction.

The filing lists a non-binding MOU between Factorial and Philenergy to explore scaling the Solstice™ platform; the agreement is explicitly subject to the negotiation and execution of definitive agreements and the satisfaction of customary conditions. This frames the item as exploratory rather than definitive.

Timing and commercial terms are not provided in the excerpt; subsequent filings (the Form S-4/proxy) may disclose material commercial or financial terms if agreements are reached.

Manufacturing collaboration could address scale-up complexity but is conditional and unspecified.

The MOU "outlines a strategic manufacturing collaboration intended to accelerate the scale up of Factorial’s Solstice™ all-solid-state battery platform." The description indicates intent to work on production scale-up but provides no capacity, investment, or timeline figures.

Operational and execution risks depend on final agreements and customary conditions; material manufacturing commitments would be disclosed in later definitive agreements and SEC filings.

Filed by Factorial Inc.

Pursuant to Rule 425

under the Securities Act of 1933, as amended

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934, as amended

Subject Company: Cartesian Growth Corporation III

(Commission File No. 001-42629)

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): February 26, 2026

 

Cartesian Growth Corporation III
(Exact name of registrant as specified in its charter)

 

Cayman Islands
(State or other jurisdiction
of incorporation)
001-42629
(Commission File Number)
N/A
(I.R.S. Employer
Identification No.)
     

505 Fifth Avenue, 15th Floor

New York, New York

(Address of principal executive offices)

10017

(Zip Code)

   
 

(212) 461-6363
(Registrant’s telephone number, including area code)

 

Not Applicable
(Former name or former address, if changed since last report)

 
           

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

xWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on
which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant   CGCTU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   CGCT   The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   CGCTW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

Item 8.01 Other Events

 

On February 26, 2026, Cartesian Growth Corporation III (“Cartesian III”) and Factorial Inc. (“Factorial”), a U.S.-based leader in solid-state battery technology, announced that Factorial has entered into a Memorandum of Understanding (“MOU”) with Philenergy Co., Ltd., a leading provider of battery equipment and infrastructure based in South Korea. The MOU outlines a strategic manufacturing collaboration intended to accelerate the scale up of Factorial’s Solstice™ all-solid-state battery platform. The MOU is non-binding and the proposed collaboration remains subject to the negotiation and execution of definitive agreements and the satisfaction of customary conditions. There can be no assurance that any definitive agreements will be entered into or that the proposed collaboration will be completed on the terms described, or at all.

 

A copy of the press release announcing the MOU is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Forward-Looking Statements

 

This Current Report on Form 8-K includes forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements may include, but are not limited to, statements regarding future events or the future financial or operating performance of Factorial or Cartesian III. For example, projections of Factorial’s future financial performance, manufacturing capabilities and operations, Factorial’s business plans, and other projections concerning key performance metrics or milestones are forward-looking statements. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements should not be relied upon as representing Cartesian III’s and Factorial’s assessments as of any date subsequent to the date of this Current Report on Form 8-K. Accordingly, undue reliance should not be placed upon the forward-looking statements. Neither Cartesian III, Factorial nor any of their respective affiliates undertake any obligation to update these forward-looking statements, except as required by law.

 

Additional Information about the Business Combination and Where to Find It

 

This communication relates to the proposed business combination between Factorial and Cartesian III (“Business Combination”) pursuant to that certain Business Combination Agreement, dated as of December 17, 2025, by and among Cartesian III, Fenway MS, Inc., a Delaware corporation, and Factorial. The proposed Business Combination will be submitted to shareholders of Cartesian III for their consideration. Cartesian III and Factorial intend to file a registration statement on Form S-4 with the Securities and Exchange Commission (“SEC”), which will include a definitive proxy statement to be distributed to Cartesian III’s shareholders in connection with Cartesian III’s solicitations of proxies from its shareholders with respect to the proposed business combination and other matters to be described in the Form S-4, as well as the prospectus relating to the offer of the securities to be issued to the stockholders of Factorial in connection with the completion of the proposed Business Combination. After that registration statement has been filed and declared effective, Cartesian III will mail a definitive proxy statement/prospectus and other relevant documents relating to the proposed Business Combination and other matters to be described in the registration statement to Factorial stockholders and Cartesian III shareholders as of a record date to be established for voting on the proposed Business Combination. Before making any voting or investment decision, Cartesian III shareholders, Factorial stockholders, and other interested persons are urged to read these documents and any amendments thereto, as well as any other relevant documents filed with the SEC by Cartesian III in connection with the proposed Business Combination and other matters to be described in those documents when they become available, because they will contain important information about Cartesian III, Factorial and the proposed Business Combination. Shareholders will also be able to obtain free copies of the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus and other documents filed by Cartesian III with the SEC, once available, without charge, at the SEC’s website located at www.sec.gov, or by directing a written request to Cartesian Growth Corporation III, 505 Fifth Avenue, 15th Floor, New York, New York 10017.

 

 

 

Participants in the Solicitation

 

Cartesian III, Factorial, and their respective directors and executive officers may be deemed to be participants in the solicitations of proxies from Cartesian III’s shareholders with respect to the proposed Business Combination and the other matters set forth in the proxy statement/prospectus. Information regarding Cartesian III’s directors and executive officers, and a description of their interests in Cartesian III is contained in Cartesian III’s final prospectus for its initial public offering filed with the SEC on May 5, 2025, which is available free of charge at the SEC’s website located at www.sec.gov, or by directing a request to Cartesian Growth Corporation III, 505 Fifth Avenue, 15th Floor, New York, New York 10017. Additional information regarding the interests of such participants in the proxy solicitation and a description of their direct and indirect interests, will be contained in the proxy statement/prospectus relating to the proposed Business Combination when it becomes available. Shareholders, potential investors and other interested persons should read the proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the sources described above.

 

This communication is not a substitute for the registration statement filed by Cartesian III or for any other document that Cartesian III and Factorial may file with the SEC in connection with the proposed Business Combination. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of other documents filed with the SEC by Cartesian III, without charge, at the SEC’s website located at www.sec.gov.

 

No Offer or Solicitation

 

This communication shall not constitute an offer to sell, or the solicitation of an offer to buy, or a recommendation to purchase, any securities, in any jurisdiction, or the solicitation of any vote, consent or approval in any jurisdiction in connection with the proposed Business Combination or any related transactions, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful. This communication is not, and under no circumstances is to be construed as, a prospectus, an advertisement or a public offering of the securities described herein in the United States or any other jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, or exemptions therefrom. INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE OFFERING OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
Number
  Description
99.1   Press Release, dated February 26, 2026.
104   Cover Page Interactive Data File, formatted in Inline XBRL

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Cartesian Growth Corporation III    
     
By: /s/ Peter Yu  
  Name: Peter Yu  
  Title: Chief Executive Officer  
     

Date: February 26, 2026

 

 

FAQ

What did Cartesian Growth Corporation III disclose about Factorial (CGCT)?

The filing discloses that Factorial entered a non-binding MOU with Philenergy to explore manufacturing collaboration to scale its Solstice™ all-solid-state battery platform, with definitive agreements yet to be negotiated.

Does the MOU between Factorial and Philenergy create binding obligations?

No, the MOU is explicitly described as non-binding, and any collaboration is subject to the negotiation and execution of definitive agreements and the satisfaction of customary conditions.

How does this 8-K relate to the proposed business combination involving Factorial and Cartesian III (CGCT)?

The 8-K notes the MOU and reiterates that Factorial and Cartesian III are pursuing a proposed business combination and intend to file a Form S-4 and definitive proxy/prospectus for shareholder consideration.

Will Cartesian III shareholders receive more information about the proposed transaction?

Yes. Cartesian III and Factorial intend to file a registration statement on Form S-4, which will include a definitive proxy statement/prospectus containing further details for shareholders.

Where can investors obtain the proxy statement and related documents for CGCT?

Investors may obtain free copies of the preliminary and definitive proxy statement/prospectus and other filings at the SEC’s website (www.sec.gov) or by written request to Cartesian Growth Corporation III at its New York address.
Cartesian Growth Corp Iii

NASDAQ:CGCT

CGCT Rankings

CGCT Latest News

CGCT Latest SEC Filings

CGCT Stock Data

353.97M
20.50M
Blank Checks
NEW YORK